Amgen Inc

AMGN
www.amgen.com
Biotechnology
1m5m15m1h4h1d1w

About Amgen Inc

Amgen is a leader in biotechnology-based human therapeutics. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen...
IndustryBiotechnologyHeadquartersONE AMGEN CENTER DRIVE, THOUSAND OAKS, CAPrimary ExchangeNASDAQEmployees31,500Listing DateJun 17, 1983Websitewww.amgen.com

Key Metrics

Market Cap$208.49B
P/E23.9x
P/B17.8x
EBITDA$4.63B
EPS$4.37
ROE74.80%
ROA9.14%
Dividend Yield2.53%

Corporate Actions

Earnings ReportSep 30, 2024
FY2024 Q3 earnings reported. Diluted EPS: $5.22.
Ex-DividendNov 18, 2024
Quarterly dividend of $2.25 per share. Ex-dividend date: November 18. Payable: December 9.
Earnings ReportDec 31, 2024
FY2024 Q4 earnings reported. Diluted EPS: $1.15.
Earnings ReportDec 31, 2024
FY2024 Q4 earnings reported. Diluted EPS: $7.56.
Ex-DividendFeb 14, 2025
Quarterly dividend of $2.38 per share. Ex-dividend date: February 14. Payable: March 7.
Earnings ReportMar 31, 2025
FY2025 Q1 earnings reported. Diluted EPS: $3.20.
Ex-DividendMay 16, 2025
Quarterly dividend of $2.38 per share. Ex-dividend date: May 16. Payable: June 6.
Earnings ReportJun 30, 2025
FY2025 Q2 earnings reported. Diluted EPS: $2.65.
Ex-DividendAug 22, 2025
Quarterly dividend of $2.38 per share. Ex-dividend date: August 22. Payable: September 12.
Earnings ReportSep 30, 2025
FY2025 Q3 earnings reported. Diluted EPS: $5.93.
Ex-DividendNov 21, 2025
Quarterly dividend of $2.38 per share. Ex-dividend date: November 21. Payable: December 12.
Earnings ReportDec 31, 2025
FY2025 Q4 earnings reported. Diluted EPS: $14.23.
Earnings ReportDec 31, 2025
FY2025 Q4 earnings reported. Diluted EPS: $2.45.
Ex-DividendFeb 13, 2026
Quarterly dividend of $2.52 per share. Ex-dividend date: February 13. Payable: March 6.
Earnings ReportMar 31, 2026
FY2026 Q1 earnings reported. Diluted EPS: $3.34.
Ex-DividendMay 15, 2026
Quarterly dividend of $2.52 per share. Ex-dividend date: May 15. Payable: June 5.
Earnings ReportJun 30, 2026
FY2026 Q2 earnings reported. Diluted EPS: $4.37.
Ex-DividendAug 21, 2026
Quarterly dividend of $2.52 per share. Ex-dividend date: August 21. Payable: September 11.

Trade AMGN on Bybit

0 ways to get exposure to Amgen Inc. Pick the one that fits your strategy.

FAQ about Amgen Inc

What is the current price of Amgen Inc?

The current price of AMGN is shown in the price section above and updated in real time during regular trading hours. If you trade AMGN Perpetuals on Bybit, pre-market, post-market, and overnight prices are also available.

How do I trade AMGN on Bybit?

Does Amgen Inc pay dividends?

What is Amgen Inc's P/E ratio, and what does it mean?

What financial results has Amgen Inc recently released?

Can I trade AMGN 24/7 on Bybit?

What payment methods can I use to buy AMGN?

How does buying AMGN on Bybit compare to using a traditional broker?

Disclaimer

The information contained herein is provided for informational purposes only and does not constitute investment, financial, trading, or other professional advice. Trading in digital assets and securities involves substantial risk of loss, including the possible loss of all principal invested. The value of digital assets and securities may be highly volatile, and past performance is not indicative of future results. Market data displayed is sourced from third-party data providers and may be subject to delays or inaccuracies. Bybit does not warrant the accuracy, completeness, or timeliness of any information displayed. All investment decisions are made solely at the investor's own risk. Independent due diligence and consultation with a licensed financial advisor are strongly recommended before making any investment decision.

--
--
Market Cap$208.49B
P/B17.8x
P/E23.9x
52-Week High/Low$456.78/$373.50
Dividend Yield2.53%
Dividend FrequencyQuarterly

Trade AMGN

News

US Dollar: Oil-driven support as Fed seen hiking – ING
Financia lJuice1h ago
Experts agree: Further US Dollar’s upside hinges on upcoming data and not hawkish Fed prospects
Financia lJuice2h ago
Federal Reserve's Goolsbee: If there is solid evidence that inflation is coming back down to 2%, I have no objection to rate cuts
PANews3h ago
Gold: Range-bound outlook with Fed headwinds – ING
Financia lJuice3h ago
Gold starts the week on the back foot as the US Dollar holds firm, oil decline limits losses.
Financia lJuice3h ago